Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis

Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis

Jagadeswara R Earla,1 George J Hutton,2 J Douglas Thornton,1 Hua Chen,1 Michael L Johnson,1 Rajender R Aparasu1 1Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX, USA; 2Department of Neurology, Baylor College of Medicine, Houston, TX, USACorresponden...

Full description

Bibliographic Details
Main Authors: Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RR
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:Patient Preference and Adherence
Subjects:
group based trajectory modelling
gbtm
adherence trajectory
multiple sclerosis
disease modifying agent
dma
fingolimod
injectable dma
Online Access:https://www.dovepress.com/comparative-adherence-trajectories-of-oral-fingolimod-and-injectable-d-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/comparative-adherence-trajectories-of-oral-fingolimod-and-injectable-d-peer-reviewed-article-PPA

Similar Items